Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle
March 21, 2022 07:00 ET
|
Quotient Limited
JERSEY, Channel Islands, March 21, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today...
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
March 08, 2022 06:45 ET
|
Quotient Limited
JERSEY, Channel Islands, March 08, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today...
Quotient Limited to Participate in the Cowen 42nd Annual Health Care Conference
February 22, 2022 09:00 ET
|
Quotient Limited
JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will...
Quotient Limited Reports Third Quarter Fiscal 2022 Results and Provides Business Update
February 08, 2022 07:00 ET
|
Quotient Limited
MosaiQ™ Solution: Transfusion Diagnostics: The Notified Body completed the assessment of the Company’s technical dossier and has advised that it will recommend the MosaiQ Expanded Immunohematology...
Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 03, 2022 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will...
Quotient Limited Announces Equity Awards
February 02, 2022 08:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards...
Quotient Limited Provides MosaiQ Regulatory & Commercial Update
February 01, 2022 08:40 ET
|
Quotient Limited
The company remains in contact with the European Notified Body and continues to anticipate approval in Q1 CY22First time attendance to Arab Health and Medlab Middle East 2022 in DubaiGenerated...
Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call
January 31, 2022 16:30 ET
|
Quotient Limited
JERSEY, Channel Islands, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third...
Quotient Limited Launches Scientific Advisory Board and Research Programs
January 26, 2022 08:30 ET
|
Quotient Limited
MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countriesQuotient’s focus is to strengthen MosaiQ scientific...
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
December 15, 2021 08:30 ET
|
Quotient Limited
Received feedback from the European notified body after review of Expanded IH submissionPleased with feedback and expect to submit a response to the questions in the next couple of weeksContinue to...